5 Results for "

BRD4-IN-8

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "BRD4-IN-8" in MCE Product Catalog:

Cat. No.: HY-160672
CAS No.: 1445992-82-4
Research Areas:  

Cancer

BRD4-IN-8 (Example 13b) is a BRD4 inhibitor .
loading...
    loading...
Cat. No.: HY-138555
CAS No.: 3026420-38-9
Purity:  99.45%
Research Areas:  

Cancer

PROTAC BRD4 Degrader-8 is a PROTAC connected by ligands for von Hippel-Lindau and BRD4, with IC50s of 1.1 nM and 1.4 nM for BRD4 BD1 and BD2, respectively. PROTAC BRD4 Degrader-8 is capable of potently degrading the BRD4 protein in PC3 prostate cancer cells .
loading...
    loading...
Cat. No.: HY-174812
BRD4 ligand 8 (Compound J558) is a BRD4 inhibitor. BRD4 ligand 8 can be used for synthesis of PROTAC BRD4 Degrader-33 (HY-174811) .
loading...
    loading...
Cat. No.: HY-185854
CAS No.: 3115940-40-1
Research Areas:  

Cancer

BRD4 degrader-8 is a BRD4-targeting degrader. BRD4 degrader-8 induces degradation of BRD4 protein via the ubiquitin-proteasome pathway. BRD4 degrader-8 can be used for the research of hematologic tumors, gastrointestinal stromal tumors, histiocytic lymphoma, non-small cell lung cancer, small cell lung cancer, lung adenocarcinoma, lung squamous cell carcinoma, pancreatic cancer, breast cancer, prostate cancer, liver cancer, skin cancer, epithelial cell carcinoma, colorectal cancer, kidney cancer, gastric cancer, head and neck cancer, nasopharyngeal cancer .
loading...
    loading...
Cat. No.: HY-184727
Research Areas:  

Cancer

CDK8/BRD4-IN-1 is a dual CDK8/BRD4 inhibitor, with an IC50 of 5.44 μM against CDK8 and an IC50 of 4.03 μM against BRD4. CDK8/BRD4-IN-1 exhibits anticancer activity against colorectal cancer. CDK8/BRD4-IN-1 can be used for the research of colorectal cancer .
loading...
    loading...